OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Close contact;Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 31
Country: Canada
Location: Greater Toronto Area
Study period: 23 Mar-03 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Lower bound: 0.13
Upper bound: 0.5
Bounds: 0.13 - 0.5
Epidemic phase: Unspecified
Reproduction number method: Empirical (contact tracing)
Reproduction number pathway: Human-human
Population group: Unspecified
Sample type: Household based
Sample size: 2658
Country: China
Location: Hong Kong
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4.82
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 4.23
Uncertainty upper value: 5.5
Combined uncertainty: 4.23 - 5.5 (95% CI)
Distribution type: Gamma
Epidemic phase: Unspecified
Sample type: Household based
Sample size: 2658
Country: China
Location: Hong Kong
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7
Unit: Percentage (%)
CFR/IFR numerator: 5
CFR/IFR denominator: 75
CFR/IFR method: Naive
Epidemic phase: Mid outbreak
Sample size: 75
Country: China
Location: Hong Kong
Study period: 24 Mar 03 2003 to 28 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 22.1
Unit: Days
Value type: Mean
Uncertainty single value: 3.1 (Standard Deviation)
Combined uncertainty: 3.1 (Standard Deviation)
Epidemic phase: Mid outbreak
Disaggregated by: Symptoms, Time
Sample size: 75
Country: China
Location: Hong Kong
Study period: 24 Mar 03 2003 to 28 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 93
Unit: Percentage (%)
CFR/IFR numerator: 70
CFR/IFR denominator: 75
CFR/IFR method: Naive
Epidemic phase: Mid outbreak
Sample size: 75
Country: China
Location: Hong Kong
Study period: 24 Mar 03 2003 to 28 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 17
Maximum age: 67
Sample size: 443
Country: China
Location: Beijing, Tianjin
Study period:  Apr 04 2004 to  Jun 06 2004
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 0.16
Unit: Days
Value type: Median
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 0.67
Combined uncertainty: 0 - 0.67 (95% CI)
Other delay start: Latent period
Other delay end: Incubation period
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 6.3
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 5.3
Uncertainty upper value: 7.3
Combined uncertainty: 5.3 - 7.3 (95% CI)
Disaggregated by: Other
Population group: Other
Sample type: Contact based
Country: China
Location: Changping, Chongwen, Dongcheng, Shijgshan, Xicheng
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 11.2
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 9.4
Uncertainty upper value: 13
Combined uncertainty: 9.4 - 13 (95% CI)
Disaggregated by: Age
Population group: Other
Sample type: Contact based
Country: China
Location: Changping, Chongwen, Dongcheng, Shijgshan, Xicheng
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Unit: Days
Value type: Median
Lower bound: 2
Upper bound: 6
Bounds: 2 - 6
Uncertainty type: IQR
Uncertainty lower value: 1
Uncertainty upper value: 14
Combined uncertainty: 1 - 14 (IQR)
Disaggregated by: Time
Country: China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 6
Unit: Days
Value type: Median
Uncertainty lower value: 0
Uncertainty upper value: 9
Combined uncertainty: 0 - 9 ()
Sample type: Hospital based
Sample size: 20
Country: Singapore
Location: Singapore
Study period: 28 Feb 02 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Unit: Days
Value type: Other
Lower bound: 2
Upper bound: 12
Bounds: 2 - 12
Disaggregated by: Level of exposure
Country: Singapore
Location: Singapore
Study period: 28 Feb 02 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 0
Unit: Percentage (%)
Lower bound: 0
Upper bound: 18.3
Bounds: 0 - 18.3
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 26.4
Combined uncertainty: 0 - 26.4 (95% CI)
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Travel based
Country: China, Hong Kong SAR,  China, Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 0
Unit: Percentage (%)
Lower bound: 0
Upper bound: 27.7
Bounds: 0 - 27.7
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 40.2
Combined uncertainty: 0 - 40.2 (95% CI)
Epidemic phase: Mid outbreak
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Travel based
Country: China, Hong Kong SAR,  China, Taiwan,  China
Location: Beijing, Hong Kong. Taipei
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4
Unit: Days
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 8
Combined uncertainty: 2 - 8 (Range)
Population group: Persons under investigation
Sample type: Travel based
Sample size: 22
Country: Hong Kong SAR,  China, Taiwan,  China
Location: Hong Kong, Taipei
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Unit: Percentage (%)
Lower bound: 2
Upper bound: 15.5
Bounds: 2 - 15.5
Epidemic phase: Post outbreak
Disaggregated by: Level of exposure
Population group: General population
Sample type: Contact based
Sex: Unspecified
Sample size: 146
Country: Vietnam
Location: Hanoi
Study period:  Oct 10 2003 to  May 05 2004
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Hospitalisation;Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare;Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Contact based
Sample size: 85
Country: Vietnam
Location: Hanoi
Study period:  Oct 10 2003 to  May 05 2004
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sample size: 85
Country: Vietnam
Location: Hanoi
Study period:  Oct 10 2003 to  May 05 2004
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Other;Sex
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sample size: 127
Country: Vietnam
Location: Hanoi French Hospital (HFH)
Study period: 26 Feb 02 2003 to 7 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sample size: 127
Country: Vietnam
Location: Hanoi French Hospital (HFH)
Study period: 26 Feb 02 2003 to 7 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.2
Unit: Percentage (%)
CFR/IFR numerator: 302
CFR/IFR denominator: 1755
CFR/IFR method: Naive
Epidemic phase: End outbreak
Sample size: 1755
Country: Hong Kong SAR,  China
Study period: 19 Mar 03 2003 to 2 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 18.1
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 10.5
Uncertainty upper value: 28.1
Combined uncertainty: 10.5 - 28.1 (95% CI)
CFR/IFR method: Adjusted
Epidemic phase: End outbreak
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period: 19 Mar 03 2003 to 27 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Unit: Days
Lower bound: 11.44
Upper bound: 11.83
Bounds: 11.44 - 11.83
Epidemic phase: Unspecified
Country: Hong Kong SAR,  China
Study period: 17 Mar 03 2003 to 10 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 1
Uncertainty upper value: 18
Combined uncertainty: 1 - 18 (Range)
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 19
Country: Canada, Hong Kong SAR,  China, United States
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.3
Unit: Days
Value type: Mean
Uncertainty single value: 4.5 (Standard Deviation)
Combined uncertainty: 4.5 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 1.4 (Shape)
Distribution parameter 2: 0.26 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 85
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3.5
Unit: Days
Value type: Mean
Uncertainty single value: 3.2 (Standard Deviation)
Combined uncertainty: 3.2 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 1.3 (Shape)
Distribution parameter 2: 0.37 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 21
Unit: Days
Value type: Mean
Uncertainty single value: 15 (Standard Deviation)
Combined uncertainty: 15 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 2.1 (Shape)
Distribution parameter 2: 0.11 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>discharge/recovery
Parameter value: 26
Unit: Days
Value type: Mean
Uncertainty single value: 11 (Standard Deviation)
Combined uncertainty: 11 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 5.6 (Shape)
Distribution parameter 2: 0.22 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 23
Unit: Days
Value type: Mean
Uncertainty single value: 11 (Standard Deviation)
Combined uncertainty: 11 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 4.1 (Shape)
Distribution parameter 2: 0.18 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 17
Unit: Days
Value type: Mean
Uncertainty single value: 16 (Standard Deviation)
Combined uncertainty: 16 (Standard Deviation)
Distribution type: Gamma
Distribution parameter 1: 1.2 (Shape)
Distribution parameter 2: 0.068 (Scale)
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 4.8
Unit: No units
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 2.2
Uncertainty upper value: 8.8
Combined uncertainty: 2.2 - 8.8 (95% CrI)
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.75
Unit: No units
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 0.65
Uncertainty upper value: 0.85
Combined uncertainty: 0.65 - 0.85 (95% CrI)
Epidemic phase: End outbreak
Reproduction number method: Compartmental model
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 354
Country: China
Location: Shanxi
Study period:  Feb 02 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4
Unit: Days
Uncertainty type: IQR
Uncertainty lower value: 2
Uncertainty upper value: 6
Combined uncertainty: 2 - 6 (IQR)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 16
Sample size: 273
Country: Canada
Location: Toronto
Study period:  Feb 02 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Close contact;Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 16
Sample size: 273
Country: Canada
Location: Toronto
Study period:  Feb 02 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Occupation;Other;Sex
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 16
Sample size: 273
Country: Canada
Location: Toronto
Study period:  Feb 02 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Value type: Mean
Lower bound: 2.02
Upper bound: 23.95
Bounds: 2.02 - 23.95
Uncertainty type: 95% CI
Uncertainty lower value: 1.83
Uncertainty upper value: 49.27
Combined uncertainty: 1.83 - 49.27 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Disaggregated by: Region
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 716
Country: Hong Kong SAR,  China, Singapore
Location: Hong Kong, Singapore
Study period: 15 Feb 02 2003 to 25 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - serial interval
Unit: Days
Value type: Mean
Lower bound: 7.42
Upper bound: 16.86
Bounds: 7.42 - 16.86
Uncertainty type: 95% CI
Uncertainty lower value: 6.77
Uncertainty upper value: 18.55
Combined uncertainty: 6.77 - 18.55 (95% CI)
Epidemic phase: Start outbreak
Disaggregated by: Region
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 716
Country: Hong Kong SAR,  China, Singapore
Location: Hong Kong, Singapore
Study period: 15 Feb 02 2003 to 25 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 23.1
Unit: Days
Value type: Unspecified
Uncertainty single value: 12.3 (Other)
Combined uncertainty: 12.3 (Other)
Epidemic phase: Unspecified
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 75
Sample size: 98
Country: China
Location: Guangzhou
Study period:  Dec 12 2002 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>discharge/recovery
Parameter value: 32.79
Unit: Days
Value type: Mean
Uncertainty single value: 10.82 ()
Combined uncertainty: 10.82 ()
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 92
Sample size: 801
Country: China
Location: Beijing
Study period:  Mar 03 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 29.02
Unit: Days
Value type: Mean
Uncertainty single value: 9.07 ()
Combined uncertainty: 9.07 ()
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 92
Sample size: 801
Country: China
Location: Beijing
Study period:  Mar 03 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Female
Minimum age: 27
Maximum age: 65
Sample size: 32
Country: Canada
Location: Toronto
Study period: 8 Mar 03 2003 to 3 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Female
Minimum age: 27
Maximum age: 65
Sample size: 32
Country: Canada
Location: Toronto
Study period: 8 Mar 03 2003 to 3 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.63
Unit: No units
Value type: Mean
Uncertainty type: 90% CI
Uncertainty lower value: 0.54
Uncertainty upper value: 2.65
Combined uncertainty: 0.54 - 2.65 (90% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample size: 57
Country: Singapore
Study period: 25 Feb 02 2003 to 22 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 0.16
Value type: Other
Uncertainty type: 90% CI
Uncertainty lower value: 0.11
Uncertainty upper value: 0.64
Combined uncertainty: 0.11 - 0.64 (90% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample size: 57
Country: Singapore
Study period: 25 Feb 02 2003 to 22 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.68
Unit: No units
Value type: Mean
Epidemic phase: Control Measures
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample size: 114
Country: Singapore
Study period: 22 Mar 03 2003 to   2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 0.071
Value type: Other
Uncertainty type: 90% CI
Uncertainty lower value: 0.049
Uncertainty upper value: 0.41
Combined uncertainty: 0.049 - 0.41 (90% CI)
Epidemic phase: Control Measures
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample size: 114
Country: Singapore
Study period: 22 Mar 03 2003 to   2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.28
Unit: No units
Value type: Mean
Epidemic phase: Control Measures
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample type: Hospital based
Sample size: 43
Country: China
Location: Beijing
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.88
Unit: No units
Value type: Mean
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample type: Hospital based
Sample size: 33
Country: China
Location: Beijing
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 0.12
Value type: Other
Uncertainty type: 90% CI
Uncertainty lower value: 0.08
Uncertainty upper value: 0.42
Combined uncertainty: 0.08 - 0.42 (90% CI)
Epidemic phase: Start outbreak
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Sample type: Hospital based
Sample size: 33
Country: China
Location: Beijing
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12.24
Unit: Percentage (%)
CFR/IFR numerator: 12
CFR/IFR denominator: 98
CFR/IFR method: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 68
Sample size: 98
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 24.5
Unit: Percentage (%)
CFR/IFR numerator: 61
CFR/IFR denominator: 249
CFR/IFR method: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 0
Maximum age: 94
Sample size: 249
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 6
Unit: Days
Value type: Median
Uncertainty type: Range [Sample]
Uncertainty lower value: 1
Uncertainty upper value: 15
Combined uncertainty: 1 - 15 (Range [Sample])
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 68
Sample size: 98
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 2
Unit: Days
Value type: Mean
Lower bound: 0
Upper bound: 14
Bounds: 0 - 14
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 68
Sample size: 98
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 14.5
Unit: Days
Value type: Mean
Lower bound: 0
Upper bound: 52
Bounds: 0 - 52
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 68
Sample size: 98
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>discharge/recovery
Parameter value: 24
Unit: Days
Value type: Mean
Lower bound: 0
Upper bound: 74
Bounds: 0 - 74
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 21
Maximum age: 68
Sample size: 98
Country: Taiwan,  China
Study period: 1 Nov 11 2002 to 31 Dec 12 2003